NCT07466381CompletedPhase 2/3
Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism
Source: ClinicalTrials.gov · Last updated 12 Mar 2026
Brief summary (registry, in English)
The aim of this study was to determine the effect of oxyhydrogen nanobubble infusion on the degree of disease, cognitive function, and quality of life of patients with parkinsonism
- Status (registry)
- Completed
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 3 Sept 2025
- Start date
- Nov 2024
- Primary completion date
- Nov 2025
- Lead sponsor
- dr. Siti Nurlaela, SpN
- Diseases
- Parkinson disease
- NCT number
- NCT07466381
What you commit to
- Study type: Interventional · Phase 2/3
- Participants enrolled: 35
- From Nov 2024 to the primary completion date, Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of malignancy and/or chemotherapy.
- History of alcohol or drug use that can induce extrapyramidal symptoms.
- Patients with heart failure requiring fluid restriction.
Other
- Patient is unwilling to undergo examination.
- Pregnancy.
- Hyperthyroidism.
- Impaired kidney function.
- Impaired liver function.
- MRI results suggest a brain tumor causing parkinsonism symptoms.
- Catalase enzyme deficiency (acatalasemia).
Who the study is looking for
- Patients who meet the criteria for parkinsonism
- 18-70 years old
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brawijaya University Hospital Coordinator of this site? Confirm its status | Malang | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.